| 8:30 AM - 9:00 AM | Check-In and Breakfast |
| 9:00 AM - 9:20 AM | Session I: Welcome Remarks
9:00 AM
Session chair: Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences
Nicholas Dirks, PhD, The New York Academy of Sciences
(Virtual) Jie Zhang, PhD, Shanghai Association for Science and Technology
Sheng Xu, PhD, Stanford University; Jeff, Aiiso Yufeng Li, CorDx
9:15 AM
Welcome Video: Nobel Laureate, James P. Allison, PhD, MD, The University of Texas MD Anderson Cancer Center |
| 9:20 AM - 10:20 AM | Session II: Advanced Cell and Immune- Based Therapies 9:20 AM Shaping the Next Generation of T Cell Engagers: Strategies for Efficacy, Selectivity, and Safety
Bas Baaten, PhD, Pfizer
9:50 AM How Lymphoma Contributes to Advanced Cell and Immune-Based Therapies
Dr. Zi-Xun Yan, PhD, Ruijin Hospital of Shanghai Jiao Tong University School of Medicine
|
| 10:20 AM - 10:55 AM | Networking Break |
| 10:55 AM - 11:55 AM | Session III: Precision Immunotherapy & Immune Modulation 10:55 AM Immunotherapy in Lung Cancer: What Is New in 2026?
Caicun Zhou, MD, PhD, Shanghai East Hospital, Cancer Institute of Tongji University School of Medicine
11:25 AM Mismatch Repair Deficient Tumor Interception by Neoantigen Surveillance
Robert Samstein, MD, PhD, Icahn School of Medicine at Mount Sinai |
| 11:55 AM - 1:00 PM | Networking Lunch |
| 1:00 PM - 2:00 PM | Session IV: Targeted and Precision Molecular Therapies 1:00 PM Stromal Targeted Anti Tumor CAR T Cells
Renier Brentjens, MD, PhD, Roswell Park Comprehensive Cancer Center
1:30 PM KRAS Mutant Cholangiocarcinoma: Novel Biological Insights and Alternative Treatment Options
Qiang Gao, MD, PhD, Zhongshan Hospital, Fudan University |
| 2:00 PM - 2:35 PM | Networking Break |
| 2:35 PM - 3:35 PM | Session V: Novel Delivery Platforms 2:35 PM A First-in-Class Pulsatile FXR Agonist for Bile-Acid-Related Liver Diseases & Cancers
Huaqiang Eric Xu, PhD, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
3:05 PM Targeted Cellular Micropharmacies and Micropharmacists
David Scheinberg, MD, PhD, Memorial Sloan Kettering Cancer Center
|
| 3:35 PM - 4:30 PM | Session VI: Panel Discussion 3:35 PM
Moderator:
Taha Merghoub, PhD, Weill Cornell Medicine
Panelists
Bas Baaten, PhD, Pfizer
Michelle Krogsgaard, PhD, NYU Grossman School of Medicine
Minhua Zheng, MD, PhD, Ruijin Hospital of Shanghai Jiao Tong University School of Medicine
Mei Tian, MD, PhD, Human Phenome Institute, Fudan University
Hongxia Wang, PhD, Fudan University Shanghai Cancer Center
|
| 4:30 PM - 4:40 PM | Closing Remarks Jiong Wu, MD, PhD, Fudan University Shanghai Cancer Center
Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences |